The world’s leading private supporter of novel research in lupus harnesses the power of innovation to drive scientific progress in this complex disease.
As reported by Lupus Daily News, a new study published in International Journal of Molecular Sciences shows that a standard lupus treatment can affect osteoporosis.
A new study finds that Benlysta, approved for lupus, may benefit patients with Sjögren’s.
As reported by Rheumatology Network, a new study published in American Journal of Public Health reports that unfair treatment by healthcare professionals is associated with disease damage among black women.
A new study suggests a target for developing a potential lupus treatment.
Learnings from two epratuzumab studies will inform progress in this complex autoimmune disease
Key DiscoveriesLupus Clinical Trials
Text to GiveDonate for Discovery
Local Lupus Events